The relationship between anti-vascular endothelial growth factor and fibrosis in proliferative retinopathy: clinical and laboratory evidence

No abstract is available for this paper.

• Publication year

  2016

• Venue

  British Journal of Ophthalmology

• Publication date

  2016-08-16

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/bjophthalmol-2015-308199PMID 27531356
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Retinal microglia: just bystander or target for therapy?

  2015cited by this paper
• TGF-β2 secretion from RPE decreases with polarization and becomes apically oriented.

  2015cited by this paper
• The role of CTGF in diabetic retinopathy.

  2015cited by this paper
• Bevacizumab modulates the process of fibrosis in vitro

  2015cited by this paper
• Diabetic Macular Edema: Pathophysiology and Novel Therapeutic Targets.

  2015cited by this paper
• Anti-vascular endothelial growth factor for proliferative diabetic retinopathy.

  2014cited by this paper
• Blockade of Jagged/Notch pathway abrogates transforming growth factor β2-induced epithelial-mesenchymal transition in human retinal pigment epithelium cells.

  2014cited by this paper
• PIGMENT EPITHELIAL TEARS ASSOCIATED WITH ANTI-VEGF THERAPY: Incidence, Long-term Visual Outcome, and Relationship with Pigment Epithelial Detachment in Age-related Macular Degeneration

  2014cited by this paper
• Osteopontin and Other Regulators of Angiogenesis and Fibrogenesis in the Vitreous from Patients with Proliferative Vitreoretinal Disorders

  2012cited by this paper
• A shift in the balance of vascular endothelial growth factor and connective tissue growth factor by bevacizumab causes the angiofibrotic switch in proliferative diabetic retinopathy

  2012cited by this paper
• Pleiotrophin promotes microglia proliferation and secretion of neurotrophic factors by activating extracellular signal-regulated kinase 1/2 pathway.

  2012cited by this paper
• Association of vascular endothelial growth factor, transforming growth factor beta, and interferon gamma gene polymorphisms with proliferative diabetic retinopathy in patients with type 2 diabetes

  2012cited by this paper
• A SYSTEMATIC REVIEW OF THE ADVERSE EVENTS OF INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR INJECTIONS

  2011cited by this paper
• Ciliary Neurotrophic Factor Induces Genes Associated with Inflammation and Gliosis in the Retina: A Gene Profiling Study of Flow-Sorted, Müller Cells

  2011cited by this paper
• CNTF Mediates Neurotrophic Factor Secretion and Fluid Absorption in Human Retinal Pigment Epithelium

  2011cited by this paper
• Preoperative intravitreal bevacizumab use as an adjuvant to diabetic vitrectomy: histopathologic findings and clinical implications.

  2011cited by this paper
• Ranibizumab and bevacizumab for neovascular age-related macular degeneration.

  2011cited by this paper
• Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.

  2011cited by this paper
• The relation between bevacizumab injection and the formation of subretinal fibrosis in diabetic patients with panretinal photocoagulation.

  2010cited by this paper
• Diabetic retinopathy

  2010cited by this paper
• Progression of tractional retinal detachment following intravitreal bevacizumab

  2009cited by this paper
• Vascular endothelial growth factor in eye disease.

  2008cited by this paper
• Microglial activation in human diabetic retinopathy.

  2008cited by this paper
• Fibrotic disorders in the eye: targets of gene therapy.

  2008cited by this paper
• The Angio-Fibrotic Switch of VEGF and CTGF in Proliferative Diabetic Retinopathy

  2008cited by this paper
• Expression of angiogenic and fibrogenic factors in proliferative vitreoretinal disorders

  2007cited by this paper
• Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy

  2007cited by this paper
• Bevacizumab as a potent inhibitor of inflammatory corneal angiogenesis and lymphangiogenesis.

  2007cited by this paper
• VEGF receptor signalling ? in control of vascular function

  2006cited by this paper
• EXPRESSION OF CONNECTIVE TISSUE GROWTH FACTOR AND ITS POTENTIAL ROLE IN CHOROIDAL NEOVASCULARIZATION

  2005cited by this paper
• Epiretinal and Vitreous Membranes: Comparative Study of 56 Cases

  2005cited by this paper
• The retinal pigment epithelium in visual function.

  2005cited by this paper
• Minocycline reduces proinflammatory cytokine expression, microglial activation, and caspase-3 activation in a rodent model of diabetic retinopathy.

  2005cited by this paper
• Differential expression of connective tissue growth factor in microglia and pericytes in the human diabetic retina

  2003cited by this paper
• Activated microglia in the human glaucomatous optic nerve head

  2001cited by this paper
• [Diabetic retinopathy].

  2001cited by this paper
• Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.

  1997cited by this paper
• Proliferative vitreoretinopathy membranes. An immunohistochemical study.

  1989cited by this paper
• Epiretinal and vitreous membranes: comparative study of 56 cases. 1981.

  1981cited by this paper

• Association between Retinal Vein Occlusion and Epiretinal Membrane Development.

  2026cites this paper
• Fibronectin Mediates Endothelial-to-Mesenchymal Transition in Retina Angiogenesis

  2025cites this paper
• Impact of Aflibercept vs Dexamethasone Treatment on Epiretinal Membrane Formation in Eyes with Diabetic Macular Edema

  2024cites this paper
• Bone morphogenetic protein 6 (BMP6) antagonises experimental proliferative vitreoretinopathy established by TGF-β2 stimulation in retinal pigment epithelial cells through modulation of the p38 and JNK MAPK pathways

  2024cites this paper
• The matricellular protein CCN5 prevents anti-VEGF drug-induced epithelial-mesenchymal transition of retinal pigment epithelium

  2024cites this paper
• Factors Affecting the Results of Ahmed Glaucoma Valve Implantation in Diabetic Neovascular Glaucoma With or Without Previous Pars Plana Vitrectomy

  2024cites this paper
• Short Term Effect of Pre-Operative Anti-VEGF on Angiogenic and Fibrotic Profile of Fibrovascular Membranes of Proliferative Diabetic Retinopathy

  2024cites this paper
• ADAMTS5 promotes neovascularization via autophagic degradation of PEDF in proliferative diabetic retinopathy.

  2023cites this paper
• Effect of a novel tyrosine kinase inhibitor nintedanib on bFGF and VEGF concentrations in a rabbit retinal vein occlusion model.

  2023cites this paper
• A Paradigm Shift in the Management Approaches of Proliferative Diabetic Retinopathy: Role of Anti-VEGF Therapy

  2022cites this paper
• Complement 3a Mediates CCN2/CTGF in Human Retinal Pigment Epithelial Cells

  2022cites this paper
• Correlation between genetic polymorphisms in apolipoprotein E and atrial fibrillation.

  2022cites this paper
• Rapid formation of macular pucker following intravitreal ranibizumab injection for branch retinal vein occlusion

  2021cites this paper
• Retinal nerve fibre layer thickness measurements in childhood glaucoma: the role of scanning laser polarimetry and optical coherence tomography

  2021cites this paper
• Tractional retinal detachment (‘crunch’ phenomenon) from intravitreal anti-vascular endothelial growth factor injection in central retinal vein occlusion

  2021cites this paper
• Vitrectomy for diabetic macular edema and the relevance of external limiting membrane

  2021cites this paper
• The Paediatric Glaucoma Diagnostic Ability of Optical Coherence Tomography: A Comparison of Macular Segmentation and Peripapillary Retinal Nerve Fibre Layer Thickness

  2021cites this paper
• Response of OCT Biomarkers Based on New Diabetic Macular Edema Classification TCED-HFV to Anti-VEGF Therapy and Its Prognostic Role in Vision Benefits

  2021cites this paper
• Yes‐associated protein is essential for proliferative vitreoretinopathy development via the epithelial‐mesenchymal transition in retinal pigment epithelial fibrosis

  2021cites this paper
• Preliminary research on the effects and mechanisms of umbilical cord‑derived mesenchymal stem cells in streptozotocin‑induced diabetic retinopathy.

  2020cites this paper
• Incidence and treatment outcomes of secondary epiretinal membrane following intravitreal injection for diabetic macular edema

  2020cites this paper
• Exosomes derived from platelet-rich plasma activate YAP and promote the fibrogenic activity of Müller cells via the PI3K/Akt pathway.

  2020cites this paper
• Inflammatory and Fibrogenic Factors in Proliferative Vitreoretinopathy Development

  2020cites this paper
• Periostin and tenascin-C interaction promotes angiogenesis in ischemic proliferative retinopathy

  2020cites this paper
• Persistent vitreous hemorrhage after intravitreal injection of dexamethasone intravitreal implant in patients with diabetic macular edema

  2019cites this paper
• Efficacy of Sunitinib, Sunitinib-Hesperetin, and Sunitinib-Doxycycline Combinations on Experimentally-Induced Corneal Neovascularization

  2019cites this paper
• Intraocular VEGF deprivation induces degeneration and fibrogenic response in retina

  2019cites this paper
• Erianin alleviates diabetic retinopathy by reducing retinal inflammation initiated by microglial cells via inhibiting hyperglycemia‐mediated ERK1/2–NF‐κB signaling pathway

  2019cites this paper
• Involvement of TRPV1 and TRPV4 Channels in Retinal Angiogenesis.

  2019cites this paper
• Anti-angiogenic effect of adiponectin in human primary microvascular and macrovascular endothelial cells.

  2019cites this paper
• Regulation and bioactivity of the CCN family of genes and proteins in obesity and diabetes

  2018cites this paper
• Rapid Progression of the Epiretinal Membrane after Intravitreal Aflibercept Injection

  2018cites this paper
• Research progress on the role of connective tissue growth factor in fibrosis of diabetic retinopathy.

  2018cites this paper
• Rapid “epiretinal membrane” development following intravitreal bevacizumab for Coats' disease

  2018cites this paper
• Nanosecond Laser Treatment for Age-Related Macular Degeneration Does Not Induce Focal Vision Loss or New Vessel Growth in the Retina.

  2018cites this paper
• Cellular stress response in human Müller cells (MIO‐M1) after bevacizumab treatment

  2017cites this paper
• Anti-fibrosis effect of nanoparticle-mediated delivery of plasminogen kringle 5.

  2017cites this paper
• Pathophysiology, screening and treatment of ROP: A multi-disciplinary perspective.

  2017cites this paper
• EDIL3 knockdown inhibits retinal angiogenesis through the induction of cell cycle arrest in vitro

  2017cites this paper